S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ADAP Adaptimmune Therapeutics PLC

1.18

-0.03 (-2.48%)

May 02 2024 - Closed

Delayed by 15 minutes

Adaptimmune Therapeutics drops 5% on $400 mixed shelf offering

To read the full story on Seeking Alpha, click here.

Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Adaptimmune Therapeutics Charts.

Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Adaptimmune Therapeutics Charts.

Adaptimmune Therapeutics PLC News

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 31 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 17 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 12 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 12 January 2024 (4 months ago) • Edgar (US Regulatory)

More Adaptimmune Therapeutics PLC News Articles

Voip Pal Com (QB)

BlackStar Enterprise (PK)

Global Developments (PK)

Brookmount Explorations (PK)

Trump Media and Technology

Globestar Therapeutics (PK)

CBD of Denver (PK)

Bell Buckle (PK)

International Star (PK)

Therapeutic Solutions (PK)

Mullen Automotive

Atacama Resources (PK)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions